Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China
· Delayed Price · Currency is CNY 29.14
+0.73 (2.57%)
Mar 10, 2026, 4:00 PM EDT
SHE:301089 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,688 | 3,567 | 6,835 | 9,072 | 10,130 | - | Upgrade
|
| Market Cap Growth | 1.89% | -47.81% | -24.66% | -10.45% | - | - | Upgrade
|
| Enterprise Value | 3,436 | 3,210 | 6,483 | 8,682 | 10,148 | - | Upgrade
|
| Last Close Price | 29.14 | 28.19 | 53.66 | 71.15 | 79.45 | - | Upgrade
|
| PE Ratio | - | - | 28.12 | 31.66 | 154.17 | - | Upgrade
|
| PS Ratio | 10.03 | 8.46 | 8.18 | 11.56 | 20.16 | - | Upgrade
|
| PB Ratio | 2.42 | 2.30 | 4.26 | 6.59 | 9.23 | - | Upgrade
|
| P/TBV Ratio | 2.56 | 2.43 | 4.50 | 7.02 | 10.00 | - | Upgrade
|
| P/FCF Ratio | - | 190.19 | - | 75.28 | - | - | Upgrade
|
| P/OCF Ratio | - | 34.75 | 253.57 | 33.74 | 174.08 | - | Upgrade
|
| EV/Sales Ratio | 9.35 | 7.61 | 7.76 | 11.06 | 20.20 | - | Upgrade
|
| EV/EBITDA Ratio | - | 518.42 | 18.72 | 24.93 | 88.37 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 21.63 | 28.21 | 120.93 | - | Upgrade
|
| EV/FCF Ratio | -37.97 | 171.12 | - | 72.04 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0.03 | 0.06 | 0.36 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.65 | - | 0.11 | 0.60 | 1.11 | Upgrade
|
| Debt / FCF Ratio | - | 0.23 | - | 0.33 | - | 3.83 | Upgrade
|
| Net Debt / Equity Ratio | -0.16 | -0.20 | -0.21 | -0.37 | -0.40 | 0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | 13.64 | -51.02 | -0.98 | -1.46 | -3.79 | 0.11 | Upgrade
|
| Net Debt / FCF Ratio | 2.78 | -16.84 | 2.14 | -4.21 | 7.98 | 0.38 | Upgrade
|
| Asset Turnover | 0.21 | 0.23 | 0.45 | 0.49 | 0.43 | 0.63 | Upgrade
|
| Inventory Turnover | 1.47 | 1.62 | 1.64 | 1.62 | 1.92 | 2.09 | Upgrade
|
| Quick Ratio | 2.98 | 2.98 | 3.02 | 1.81 | 2.39 | 0.60 | Upgrade
|
| Current Ratio | 4.69 | 4.10 | 4.23 | 2.39 | 3.13 | 0.99 | Upgrade
|
| Return on Equity (ROE) | -3.07% | -1.26% | 16.32% | 23.17% | 8.28% | 25.81% | Upgrade
|
| Return on Assets (ROA) | -2.41% | -1.43% | 10.17% | 11.89% | 4.48% | 10.45% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.25% | -3.29% | 21.58% | 35.42% | 12.08% | 24.36% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.30% | -2.60% | 18.20% | 21.70% | 7.40% | 26.80% | Upgrade
|
| Earnings Yield | -1.29% | -0.56% | 3.56% | 3.16% | 0.65% | - | Upgrade
|
| FCF Yield | -2.45% | 0.53% | -2.32% | 1.33% | -0.54% | - | Upgrade
|
| Dividend Yield | - | - | 0.47% | 0.56% | 0.13% | - | Upgrade
|
| Payout Ratio | - | - | 20.85% | 5.23% | 12.05% | 8.51% | Upgrade
|
| Buyback Yield / Dilution | 9.23% | 1.32% | 0.22% | -26.78% | -5.03% | -0.59% | Upgrade
|
| Total Shareholder Return | 9.23% | 1.32% | 0.69% | -26.22% | -4.91% | -0.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.